Effects of L-carnitine supplementation on inflammatory factors and malondialdehyde in patients with nonalcoholic steatohepatitis (NASH)
Effect Decrease
Values Table 2
Trial Design Randomized trial
Trial Length 1-6 months
Number of Subjects 72
Sex Both Genders
Notes for this study:
In a randomized, double-blind, controlled trial, 72 participants with NASH took 2000 mg l-carnitine with calorie restriction or placebo with calorie restriction for 12 weeks.

The carnitine group saw a greater reaction in hs-CRP, transforming growth factor beta, TNF-a, and malondialdehyde, which continued to be the case when adjusted for baseline values, age, and baseline BMI.